ReviewCurrent neuropharmacology2022

Stem Cell-based and Advanced Therapeutic Modalities for Parkinson's Disease: A Risk-effectiveness Patient-centered Analysis.

Sarvenaz Salahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.